Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion type Assertion NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_head.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion description "[The cancer antigen CA 15-3 has been used as a possible serum marker of occult and recurrent breast carcinoma, either alone or in combination with other tumor markers such as HER2/neu, that has evolved as a major classifier of invasive breast cancer and target of therapy for the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion evidence source_evidence_literature NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion SIO_000772 24674678 NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion wasDerivedFrom befree-2016 NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.
- NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_assertion wasGeneratedBy ECO_0000203 NP1167860.RAlJztbEi7DLqZSm2qQjIcrInqTtUPBzLL6rYcq3B7_yM130_provenance.